News
-
-
COMMUNIQUÉ DE PRESSE
Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Alset AI Ventures announces full repayment of $3.7M loan with interest to Cedarcross International Technologies, strengthening balance sheet. Focus on expanding AI and cloud computing investments -
COMMUNIQUÉ DE PRESSE
Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Battery X Metals Inc. announces initiatives to strengthen balance sheet, including debt settlements and corporate agreements. Appointment of Howard Blank as independent director. Focus on clean energy transition and battery metals market -
COMMUNIQUÉ DE PRESSE
APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
APONTIS PHARMA AG waives minimum acceptance condition in Zentiva's public purchase offer. Around 60% shares tendered. Management recommends acceptance. Cash consideration offers premium -
-
-
COMMUNIQUÉ DE PRESSE
First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Pentixapharm starts Phase I/II trial treating leukemia with Lu177-PentixaTher, a targeted radiotherapy. Study aims to expand treatment options for hematologic malignancies -
-
-
